A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy
Grace K. Dy, Dheerendra Prasad, Prasanna Kumar, Kristopher Attwood, Alex A. Adjei
Topics & Concepts
NintedanibMedicinePlaceboInternal medicinePneumonitisCommon Terminology Criteria for Adverse EventsRadiation therapyIdiopathic pulmonary fibrosisAdverse effectRandomized controlled trialGastroenterologyClinical endpointOncologySurgeryLungPathologyAlternative medicineInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and MutationsPolyomavirus and related diseases